Myopia control

Myopia often progresses silently — especially in children. The global prevalence of myopia is rising rapidly, with some sources predicting that 50% of the world’s population will be myopic within the next 30 years.

At OPÉA, we offer a structured myopia control program that includes treatment options such as specialized lenses (MiyoSmart, MiSight) and low-dose atropine drops.

Our monitoring tools include:
• Cycloplegic eye exam
• Lenses designed to slow myopia progression (Hoya MiyoSmart, CooperVision MiSight)
• Diluted atropine eye drops (by prescription)
• Parental education and ergonomic recommendations